AVE vs CGS

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

AVE

AVECHO FPO [AVE]

55MEDIUM

CGS

COGSTATE FPO [CGS]

57MEDIUM

Score Breakdown

AVE CGS
Technical
55
61
Catalyst
59
55
Sentiment
50
50
Fundamental
44
99
Momentum
71
64
Risk Gate
45
45

Key Metrics

AVE Metric CGS
$77.3MMarket Cap$523.4M
3.9MAvg Volume (20d)699K
N/AShort Interest+0.0%
$0.02752-Week High$3.230
$0.00552-Week Low$1.690
-4.6%Daily Change-0.3%
$0.021Reference Price$3.070
-268.2%ROE+22.5%
N/AProfit Margin+19.5%

Active Signals

AVE Signals

●Drifting lower — down 8.7% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Trading above the 200-day average — the long-term trend is on your side
●Adequate cash runway (7 quarters)
●Very high P/S ratio (104.8x)
●Revenue in sharp decline (-89%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●Small-cap ($20-100M)

CGS Signals

●Beating the Small Ords index — relative strength of 1.21, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Moderate P/S ratio (8.6x)
●Moderate revenue growth (+16%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+10pts)
●Near 52-week high (90% of range)

Ask Scout AI to compare AVE and CGS in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

CGS vs SOM →CMP vs EYE →EYE vs PIQ →IIQ vs LGP →ARX vs AVE →
AVE Full Analysis → CGS Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).